| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| cart-19 | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] |
2.45 | phase 1 | unknown |
| cart-19 | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma Non-Hodgkin[MeSHID:D008228] Malignant lymphoma lymphocytic intermediate differentiation diffuse[MeSHID:D020522] leukemia[MeSHID:D007938] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] Chronic Lymphocytic Leukemia[MeSHID:D015451] Hematopoietic Neoplasms[MeSHID:D019337] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] B-Cell Lymphomas[MeSHID:D016393] Lymph[MeSHID:D008196] Prolymphocytic Leukemia[MeSHID:D015463] Follicular[MeSHID:D008224] |
2.45 | phase 2/3 | unknown |
| cart-19 | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] |
2.45 | phase 2 | unknown |
| cart-19 | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] B-Cell Lymphomas[MeSHID:D016393] |
2.45 | phase 2 | unknown |
| cart-19 | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma Non-Hodgkin[MeSHID:D008228] Malignant lymphoma lymphocytic intermediate differentiation diffuse[MeSHID:D020522] leukemia[MeSHID:D007938] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] Chronic Lymphocytic Leukemia[MeSHID:D015451] Hematopoietic Neoplasms[MeSHID:D019337] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] B-Cell Lymphomas[MeSHID:D016393] Lymph[MeSHID:D008196] Prolymphocytic Leukemia[MeSHID:D015463] Follicular[MeSHID:D008224] |
2.45 | phase 2 | unknown |
| cart-19 | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] B-Cell Lymphomas[MeSHID:D016393] |
2.45 | phase 1 | unknown |
| cart-19 | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] B-Cell Lymphomas[MeSHID:D016393] |
2.45 | phase 2/3 | unknown |
| cart-19 | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] |
2.45 | phase 2/3 | unknown |
| cart-19 | b-lymphocyte surface antigen b4 | NA | Successful target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Lymphoma Non-Hodgkin[MeSHID:D008228] Malignant lymphoma lymphocytic intermediate differentiation diffuse[MeSHID:D020522] leukemia[MeSHID:D007938] Diffuse Large B-Cell Lymphoma[MeSHID:D016403] Chronic Lymphocytic Leukemia[MeSHID:D015451] Hematopoietic Neoplasms[MeSHID:D019337] Precursor Cell Lymphoblastic Leukemia Lymphoma[MeSHID:D054198] B-Cell Lymphomas[MeSHID:D016393] Lymph[MeSHID:D008196] Prolymphocytic Leukemia[MeSHID:D015463] Follicular[MeSHID:D008224] |
2.45 | phase 1 | unknown |
| click here to return to the previous page | ||||||||